论文部分内容阅读
目的对胺碘酮在快速型心律失常中的应用价值进行评价。方法取我院2015年1月份到2016年8月份收治的80例快速型心律失常患者为研究对象。分成两组,40例患者予以常规治疗,设为对照组。40例患者同时取胺碘酮进行治疗,设为实验组。全程关注患者的治疗情况,并进行观察和比较。结果实验组的总有效率较高,与对照组数据比较差异性明显,证实存在统计学意义,P<0.05;实验组治疗后的血压、心率较优,与对照组数据比较差异性明显,证实存在统计学意义,P<0.05。结论对快速型心律失常患者应用胺碘酮进行治疗,对患者心率、血压有改善效果,有利于病情的改善。
Objective To evaluate the value of amiodarone in tachyarrhythmia. Methods Totally 80 patients with tachyarrhythmia treated in our hospital from January 2015 to August 2016 were enrolled in this study. Divided into two groups, 40 patients were routinely treated as a control group. Forty patients were treated with amiodarone at the same time and set as the experimental group. Full attention to the patient’s treatment, and to observe and compare. Results The total effective rate in the experimental group was higher than that in the control group, which showed significant difference (P <0.05). The blood pressure and heart rate in the experimental group were better than those in the control group There was statistical significance, P <0.05. Conclusions The application of amiodarone in patients with tachyarrhythmias has the effect of improving the heart rate and blood pressure of the patients and is beneficial to the improvement of the condition.